Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.
about
Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand?Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcomaFolate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis.Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.Emerging drugs for malaria.Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update.Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity?The role and utility of measuring red blood cell methotrexate polyglutamate concentrations in inflammatory arthropathies--a systematic review.The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy.Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome.Pharmacokinetics, pharmacodynamics and toxicities of methotrexate in healthy and collagen-induced arthritic rats.Pharmacogenetics of inflammatory bowel disease.Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis.Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis.Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients.Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.Genetic polymorphisms predicting methotrexate blood levels and toxicity in adult non-Hodgkin lymphoma.Institutional profile: The Carney Centre for Pharmacogenomics: a New Zealand focus for personalized medicine research.
P2860
Q34559803-E9EDD1F3-86D4-4949-B8F8-91941379C6AAQ36104458-FDABB042-75CA-4B65-8389-99BDE63AE1F0Q36789432-A2782F59-662C-4C48-918E-6509ED297C30Q37158455-C1C6A66E-5344-4BB8-8B91-0F8DB7BA96A1Q37683906-9D96DDEA-8F55-4F3D-8D76-4E0A153FBC98Q38022258-C044540E-63EE-4057-84E1-AAF29B0E1701Q38027179-1DF03E61-A949-4F15-AE6C-BA4F67A03825Q38195630-4F839008-3A2F-427C-A1FE-197529D6223FQ38267703-AE5DB750-72E7-4DBB-863D-1459A6D25CDCQ38357969-3CC32716-A00C-4C6B-8356-FA79F67E3971Q38648460-A406B7B6-F640-436A-8BCD-DA4EFD0820D7Q40564193-F48676F4-47B8-40F1-88B5-7E12C1CCEE80Q40772231-52C52403-EE72-44E2-B088-16E411EF8585Q41673937-4CD06213-6D3B-41FC-A68C-D6A1A7D2C2D5Q42442252-7774DE47-3265-4A8F-AA0A-C06849C4F824Q44050282-080966FD-6F60-4424-90BD-BCB52499DA6DQ44621683-626244BB-A6F4-4B63-A406-3C86F16ABBD1Q45055039-67A926AC-FDB4-41EB-A7E1-2ED9C66F07D4Q49680083-594F2BD9-85DF-4E40-A2FD-4A6DEA0B8BFAQ50856551-E4A09B23-9F2C-431A-AC14-BA6CF0BFFF48Q53128897-E26983C9-DCF3-40E3-B983-B2C6A7514C54
P2860
Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Effect of genetic polymorphism ...... therapy in rheumatic diseases.
@en
Effect of genetic polymorphism ...... therapy in rheumatic diseases.
@nl
type
label
Effect of genetic polymorphism ...... therapy in rheumatic diseases.
@en
Effect of genetic polymorphism ...... therapy in rheumatic diseases.
@nl
prefLabel
Effect of genetic polymorphism ...... therapy in rheumatic diseases.
@en
Effect of genetic polymorphism ...... therapy in rheumatic diseases.
@nl
P2860
P356
P1433
P1476
Effect of genetic polymorphism ...... therapy in rheumatic diseases.
@en
P2093
Lisa K Stamp
Rebecca L Roberts
P2860
P304
P356
10.2217/PGS.11.86
P577
2011-10-01T00:00:00Z